These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38238225)

  • 1. Bleeding Risk in Hemodialysis Patients.
    van Eck van der Sluijs A; Pai P; Zhu W; Ocak G
    Semin Nephrol; 2023 Nov; 43(6):151478. PubMed ID: 38238225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anticoagulation of the extracorporeal circuit in chronic hemodialysis].
    Ryckelynck JP; Chouraqui D; Lobbedez T
    Nephrologie; 1998; 19(4):223-5. PubMed ID: 9675763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major bleeding in hemodialysis patients using unfractionated or low molecular weight heparin: a single-center study.
    Nadarajah L; Fan S; Forbes S; Ashman N
    Clin Nephrol; 2015 Nov; 84(5):274-9. PubMed ID: 26365216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: A systematic review and meta-analysis.
    Van Der Meersch H; De Bacquer D; De Vriese AS
    Am Heart J; 2017 Feb; 184():37-46. PubMed ID: 27892885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleeding in patients using new anticoagulants or antiplatelet agents: risk factors and management.
    Levi MM; Eerenberg E; Löwenberg E; Kamphuisen PW
    Neth J Med; 2010 Feb; 68(2):68-76. PubMed ID: 20167958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pros and cons of antithrombotic therapy in end-stage kidney disease: a 2019 update.
    Burlacu A; Genovesi S; Ortiz A; Combe C; Basile C; Schneditz D; van der Sande F; Popa GT; Morosanu C; Covic A
    Nephrol Dial Transplant; 2019 Jun; 34(6):923-933. PubMed ID: 30879070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing arteriovenous shunt failure in hemodialysis patients: a population-based cohort study.
    Fan PY; Lee CC; Liu SH; Li IJ; Weng CH; Tu KH; Hsieh MY; Kuo CF; Chang TY; Tian YC; Yang CW; Wu HH
    J Thromb Haemost; 2019 Jan; 17(1):77-87. PubMed ID: 30472783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Atrial fibrillation and anticoagulation in hemodialysis patients: A complex decision].
    Delanaye P; Bouquegneau A; Dubois BE; Sprynger M; Mariat C; Krzesinski JM; Lancellotti P
    Nephrol Ther; 2017 Apr; 13(2):59-66. PubMed ID: 28216253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents.
    Levi M; Eerenberg E; Kamphuisen PW
    J Thromb Haemost; 2011 Sep; 9(9):1705-12. PubMed ID: 21729240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and stage 5 chronic kidney disease under dialysis: A systematic review and meta-analysis of randomized controlled trials.
    de Lucena LA; Freitas MAA; Souza AKC; Silva CHA; Watanabe JMF; Guedes FL; Almeida JB; de Oliveira RA
    J Thromb Thrombolysis; 2024 Mar; 57(3):381-389. PubMed ID: 38281231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of major bleeding in patients with venous thromboembolism treated with rivaroxaban or with heparin and vitamin K antagonists.
    Di Nisio M; Ageno W; Rutjes AW; Pap AF; Büller HR
    Thromb Haemost; 2016 Jan; 115(2):424-32. PubMed ID: 26511068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use and safety of unfractionated heparin for anticoagulation during maintenance hemodialysis.
    Shen JI; Winkelmayer WC
    Am J Kidney Dis; 2012 Sep; 60(3):473-86. PubMed ID: 22560830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic medications in dialysis patients: a double-edged sword.
    Vlachopanos G; Ghalli FG
    J Evid Based Med; 2017 Feb; 10(1):53-60. PubMed ID: 28276631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of direct oral anticoagulants vs vitamin K antagonists in patients with atrial fibrillation and end-stage renal disease on hemodialysis: A systematic review and meta-analysis.
    Kyriakoulis I; Adamou A; Stamatiou I; Chlorogiannis DD; Kardoutsos I; Koukousaki D; Ntaios G
    Eur J Intern Med; 2024 Jan; 119():45-52. PubMed ID: 37648582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation on chronic hemodialysis: a meta-analysis of randomized controlled trials.
    Navalha DDP; Felix N; Nogueira A; Clemente M; Marinho AD; Ferreira ROM; Pasqualotto E; Dagostin CS; Pinto LCS; Fernandes GC
    Int Urol Nephrol; 2024 Jun; 56(6):2001-2010. PubMed ID: 38153665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [T2HD Study. Oral anticoagulants and antiplatelet agents: Practices, benefits, and risks in the chronic hemodialysis population. Observational data].
    Martin A; Thilly N; Ayav C; Clerc-Urmes I; Held P; Frimat L; Peters NO
    Nephrol Ther; 2016 Jun; 12(3):156-65. PubMed ID: 26631311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Established and new-generation antithrombotic drugs in patients with cirrhosis - possibilities and caveats.
    Lisman T; Kamphuisen PW; Northup PG; Porte RJ
    J Hepatol; 2013 Aug; 59(2):358-66. PubMed ID: 23548197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are direct oral anticoagulants such as edoxaban safer than heparin or vitamin K-antagonists when intracranial hemorrhage occurs?
    Dempfle CE
    Thromb Res; 2014 Apr; 133(4):521-2. PubMed ID: 24568776
    [No Abstract]   [Full Text] [Related]  

  • 19. Vitamin K antagonist use and mortality in dialysis patients.
    Voskamp PWM; Rookmaaker MB; Verhaar MC; Dekker FW; Ocak G
    Nephrol Dial Transplant; 2018 Jan; 33(1):170-176. PubMed ID: 28992189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bleeding risk and perioperative management of patients anticoagulated with vitamin K antagnosists].
    Angelo M; Stockner I; Wiedermann CJ
    Wien Med Wochenschr; 2008; 158(21-22):615-20. PubMed ID: 19052707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.